Clinical utility of noninvasive fetal trisomy (NIFTY) test--early experience. - Wikidata - wikimedia - TriplyDB

Clinical utility of noninvasive fetal trisomy (NIFTY) test--early experience.

Clinical utility of noninvasive fetal trisomy (NIFTY) test--early experience.

http://www.wikidata.org/entity/Q36353229

about

Non-invasive prenatal testing: a review of international implementation and challenges Non-invasive prenatal testing for fetal chromosomal abnormalities by low-coverage whole-genome sequencing of maternal plasma DNA: review of 1982 consecutive cases in a single center Single-nucleotide polymorphism-based noninvasive prenatal screening in a high-risk and low-risk cohort Analysis of cell-free DNA in maternal blood in screening for fetal aneuploidies: updated meta-analysis.Non-invasive prenatal testing for aneuploidy: current status and future prospects.Noninvasive prenatal testing for trisomy 21: challenges for implementation in Australia.Clinical implementation of NIPT - technical and biological challenges.Initial experience with non-invasive prenatal testing of cell-free DNA for major chromosomal anomalies in a clinical setting.[Towards the perfect child].First-trimester Down syndrome screening using additional serum markers with and without nuchal translucency and cell-free DNA.Clinical application of massively parallel sequencing-based prenatal noninvasive fetal trisomy test for trisomies 21 and 18 in 11,105 pregnancies with mixed risk factors.Genomics-based non-invasive prenatal testing for detection of fetal chromosomal aneuploidy in pregnant women.Has noninvasive prenatal testing impacted termination of pregnancy and live birth rates of infants with Down syndrome?Reproductive management through integration of PGD and MPS-based noninvasive prenatal screening/diagnosis for a family with GJB2-associated hearing impairment.A cost-effectiveness analysis comparing different strategies to implement noninvasive prenatal testing into a Down syndrome screening program.Fetal aneuploidy screening by maternal plasma DNA sequencing: ‘False positive’ due to confined placental mosaicism Secondary findings from non-invasive prenatal testing for common fetal aneuploidies by whole genome sequencing as a clinical service

P2860

Q26999426-73D67A14-1A2C-47AB-9D83-99C95B49C730 Q27007785-3C24610B-46FC-4D11-925C-AD8A83E43027 Q34088575-159D085F-75F3-460B-8371-34C1A930FEA0 Q35552815-E924AFB5-0BFB-407F-9161-22F943B3590C Q38114375-8399839E-AA50-4C53-9124-0B621D8B3E28 Q38125511-6AE1532B-7C3D-46BF-8B7D-2FDBDE1AA4FA Q38418240-20ECF06E-C5AD-43FB-AADF-51E70932DE0F Q38419642-15C191E6-80BC-49A0-8E57-DDA26F9FA0C0 Q43758297-9988A9C5-B625-4063-BB52-7E6AAD834F8A Q44729421-90C21A84-AE86-4D25-8FC9-8CA54A340A06 Q46446186-E0BB08FD-B673-4C37-BDCF-EB8CA982D88B Q47618331-C14BA802-AE00-4D55-835A-B0E5109BC30F Q48352229-70D929B8-7B13-4214-9654-6FD96E63603C Q50351727-3718E46C-68FA-45A6-81DD-BDB938542F41 Q51056545-875C9884-71A2-41C2-AF14-DC231B1BDAA3 Q58028950-DA24C50D-685B-47F6-8CD0-3BD8370F9D7A Q58028956-1136B509-F37A-4FB2-9A71-87942F59D432

P2860

Clinical utility of noninvasive fetal trisomy (NIFTY) test--early experience.

http://www.wikidata.org/entity/Q36353229

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh

2012年學術文章

@zh-hant

name

Clinical utility of noninvasive fetal trisomy (NIFTY) test--early experience.

@ast

Clinical utility of noninvasive fetal trisomy (NIFTY) test--early experience.

@en

type

label

Clinical utility of noninvasive fetal trisomy (NIFTY) test--early experience.

@ast

Clinical utility of noninvasive fetal trisomy (NIFTY) test--early experience.

@en

prefLabel

Clinical utility of noninvasive fetal trisomy (NIFTY) test--early experience.

@ast

Clinical utility of noninvasive fetal trisomy (NIFTY) test--early experience.

@en

P1433

Q36353229-0C735FB7-6CD4-4F87-9549-B8DB5FE984B6

P1476

Q36353229-A79D6C7C-C094-4ECE-B4C9-EB092CD49F4D

P2093

Q36353229-668EB905-2D78-4E4D-8D41-58DE304E7AF9

Q36353229-82C23D1F-D423-4708-8774-E833EB2CE6C1

Q36353229-ADF67CD7-C720-4D53-9320-CE55FE0DC65C

Q36353229-BE48610A-46FD-4822-8A2D-2F952ACD799A

Q36353229-D1B4A8E6-67FF-4B8D-92F1-DB03F711D962

Q36353229-DA8085B6-1555-4741-B3A9-20CF85776536

Q36353229-EC73F6A3-2DBD-4CEA-9CBE-94EB5B237F8B

P2860

Q36353229-086CD827-EB14-48EE-B295-83EC6BB5E5BD

Q36353229-178250AB-92E4-403E-BBE6-0C6F88EE5AD2

Q36353229-5D1691C0-B57C-46B3-9E46-1100FCDF3307

Q36353229-711F87D1-1EA2-4387-9697-1658F5850BF0

Q36353229-751AEB0C-2BA3-4F48-B412-3B0D5D1F981B

Q36353229-75D89582-340C-4D74-9767-84E47C839241

Q36353229-91EE84E2-943D-4572-BEED-1A091CC079B4

Q36353229-B08EDC14-DB59-4FC5-BC57-272A9C8CB018

Q36353229-BC139522-50D2-4C7A-969D-E120547B2D7E

Q36353229-C4CA609D-26E3-4F52-9E1B-DEFF890CA121

P304

Q36353229-2EFFA2D8-39F0-481F-8C8E-B94CABADB1B1

P31

Q36353229-AF6980B7-BA0E-4490-8151-A64C764278AE

P356

Q36353229-BC847A74-3E17-4199-8BAB-73316285D9CD

P433

Q36353229-617D8C95-2457-4144-8892-32CD8F852A09

P478

Q36353229-62A5D2CD-11DA-4591-8620-8D5D1FCE7568

P50

Q36353229-D705AB25-2297-4968-BD2B-D4B5318DD1B9

P577

Q36353229-C6B3D207-4A2D-44EB-A0E3-DA0DD3A20BE4

P5875

Q36353229-91C56300-C573-40EA-8F4A-D3050DFBAC5F

P698

Q36353229-538242CB-EC66-4BD2-BEDC-602AA3740650

P932

Q36353229-9285FE7C-61D6-4396-B411-61E00E04AE46

P356

14767058.2012.678442

P1433

Journal of Maternal-Fetal and Neonatal Medicine

P1476

Clinical utility of noninvasive fetal trisomy (NIFTY) test--early experience

@en

P2093

Hoi Yan Joyce Ng

http://www.w3.org/2001/XMLSchema#string

Hon Yee Connie Chan

http://www.w3.org/2001/XMLSchema#string

Mei Ki Chan

http://www.w3.org/2001/XMLSchema#string

Pui Shan Salome Lo

http://www.w3.org/2001/XMLSchema#string

Ritsuko K Pooh

http://www.w3.org/2001/XMLSchema#string

Tik Yee Koo

http://www.w3.org/2001/XMLSchema#string

Wai Sze Kim Chan

http://www.w3.org/2001/XMLSchema#string

P2860

Noninvasive prenatal diagnosis of fetal trisomy 18 and trisomy 13 by maternal plasma DNA sequencing

DNA sequencing of maternal plasma reliably identifies trisomy 18 and trisomy 13 as well as Down syndrome: an international collaborative study.

Prenatal Detection of Down Syndrome using Massively Parallel Sequencing (MPS): a rapid response statement from a committee on behalf of the Board of the International Society for Prenatal Diagnosis, 24 October 2011.

Noninvasive prenatal diagnosis: pregnant women's interest and expected uptake.

Screening for fetal aneuploidies at 11 to 13 weeks.

Pregnant women's responses to information about an increased risk of carrying a baby with Down syndrome.

Optimal detection of fetal chromosomal abnormalities by massively parallel DNA sequencing of cell-free fetal DNA from maternal blood.

Noninvasive prenatal diagnosis of common fetal chromosomal aneuploidies by maternal plasma DNA sequencing.

First trimester combined screening for Trisomy 21 in Hong Kong: outcome of the first 10,000 cases.

Presence of fetal DNA in maternal plasma and serum

P304

1856-1859

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3109/14767058.2012.678442

http://www.w3.org/2001/XMLSchema#string

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

25

http://www.w3.org/2001/XMLSchema#string

P50

P577

2012-04-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

223984139

http://www.w3.org/2001/XMLSchema#string

P698

22471583

http://www.w3.org/2001/XMLSchema#string

P932

3483059

http://www.w3.org/2001/XMLSchema#string